about
Elevated blood pressure and cardiac hypertrophy after ablation of the gly96/IEX-1 geneDeveloping cell-specific antibodies to endothelial progenitor cells using avian immune phage display technology.Regulation of relB in dendritic cells by means of modulated association of vitamin D receptor and histone deacetylase 3 with the promoter.Deficiency of heme oxygenase-1 impairs renal hemodynamics and exaggerates systemic inflammatory responses to renal ischemia.Fibrosis with inflammation at one year predicts transplant functional decline.Changes in immunological profile of allogeneic mesenchymal stem cells after differentiation: should we be concerned?Inhibition of T cell activation and autoimmune diabetes using a B cell surface-linked CTLA-4 agonist.Surface glycosylation profiles of urine extracellular vesiclesEffects of 1alpha,25(OH)2D3 and its analogs on dendritic cell function.Back from the brink: a mesenchymal stem cell infusion rescues kidney function in acute experimental rhabdomyolysis.Mesenchymal stem cell effects on T-cell effector pathways.Mesenchymal Stem Cell-derived Extracellular Vesicles: Toward Cell-free Therapeutic Applications.Renal hemodynamic, inflammatory, and apoptotic responses to lipopolysaccharide in HO-1-/- miceMultiple potential clinical benefits for 1alpha,25-dihydroxyvitamin D3 analogs in kidney transplant recipients.Macromolecular crowding meets oxygen tension in human mesenchymal stem cell culture - A step closer to physiologically relevant in vitro organogenesis.Blood pressure measurement in peritoneal dialysis: which method is best?Interleukin-1 accounts for intrarenal Th17 cell activation during ureteral obstruction.Chondrogenic differentiation increases antidonor immune response to allogeneic mesenchymal stem cell transplantation.Anti-donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far?Concise review: adult mesenchymal stromal cell therapy for inflammatory diseases: how well are we joining the dots?Autologous and allogeneic mesenchymal stem cells in organ transplantation: what do we know about their safety and efficacy?Getting to know the extracellular vesicle glycome.Direct transcriptional regulation of RelB by 1alpha,25-dihydroxyvitamin D3 and its analogs: physiologic and therapeutic implications for dendritic cell function.The influence of hypoxia on the differentiation capacities and immunosuppressive properties of clonal mouse mesenchymal stromal cell lines.Spatial and Temporal Clustering of Anti-Glomerular Basement Membrane Disease.Correlation of quantitative digital image analysis with the glomerular filtration rate in chronic allograft nephropathy.Diet and Major Renal Outcomes: A Prospective Cohort Study. The NIH-AARP Diet and Health Study.Culture expanded primary chondrocytes have potent immunomodulatory properties and do not induce an allogeneic immune response.Blockade of T cell activation using a surface-linked single-chain antibody to CTLA-4 (CD152).Distinctive Surface Glycosylation Patterns Associated With Mouse and Human CD4+ Regulatory T Cells and Their Suppressive Function.Bad Memory: CD4 T Cell Presensitization Fosters Antibody-Mediated Kidney Transplant Rejection.Kidney transplant function and histological clearance of virus following diagnosis of polyomavirus-associated nephropathy (PVAN).Distinctive dendritic cell modulation by vitamin D(3) and glucocorticoid pathways.Kidney transplantation without calcineurin inhibitors using sirolimus.Synergistic effects of CTLA-4Ig and sirolimus on orthotopic lung-allograft survival and histology.Generation of antigen-specific, interleukin-10-producing T-cells using dendritic cell stimulation and steroid hormone conditioning.Kidney transplantation for primary focal segmental glomerulosclerosis: outcomes and response to therapy for recurrence.The renal lymph node and immune tolerance to filtered antigens.Decline in native renal function early after bladder-drained pancreas transplantation alone.Oral paricalcitol reduces the prevalence of posttransplant hyperparathyroidism: results of an open label randomized trial.
P50
Q28589777-A4A3F224-87EC-41A4-A065-4B6B4050AF90Q33905132-54945E98-1AE5-4F38-B2E9-D2ED7ECEA226Q34085202-8CFA25D9-F12F-44DB-B046-E2754DB2B6B0Q34170314-2656724D-86B1-4D68-B1A5-C69665FD7926Q34457101-67A426AC-5FB5-40D4-BC6C-7DEFDE062B75Q34803754-9F29C763-F134-4D9C-B366-E38EA042C23DQ34872848-108BA979-F568-4155-B2CF-6EAF7A36682CQ34999330-C2416F26-0B21-4459-96BD-72C47B0D3740Q35042199-0C0043CF-A042-475D-8832-3767B68DA2BAQ35115499-27AAA546-DA40-466F-B446-1F38B944A8E4Q35558505-6964D4F1-19B3-4A6F-998B-C06441A15877Q35594874-BEDDADFC-79FF-49D3-8229-133785F9329BQ35855605-07B2FE92-DE18-467C-99E8-5B5723C0AE45Q36199311-BFEFC1AB-DCD6-4A7D-89F9-E90395D3C7BFQ37141160-B05ECA2F-7AFB-462E-93E6-EDDE75934474Q37232295-837BDEEE-F2F6-46D6-A0E2-72D0C2CA8A69Q37553560-DF5C1600-753A-448E-A1FA-EB22F5385B1AQ37620828-4616DD35-F323-4272-B7AA-2B206E8CFE8AQ38064659-AB1C5740-BA66-4A08-9248-75EAAAA60948Q38114405-B01A06AD-F298-4DED-B522-CE13EEDB8F3DQ38174034-E20B43E8-9696-4194-9846-B714F8A46642Q38293737-2F889AE9-853D-4EA6-B2C7-F2DF4AB1979EQ38350061-535A1FA3-7B23-4F60-B1A5-677FF42CE10DQ39000634-34F91C93-142B-4204-BA0E-3F713164CCECQ39612845-2D070953-00F8-4E3A-A80F-26B7F755DF57Q39676693-E43119BD-DBD4-46D8-9F7E-F7AB6DF59867Q40359643-91F35CA0-F169-4F2B-B059-333B59D127B7Q40401847-CDA1E541-B92C-4745-AF48-6765EE467103Q40884227-91A41E9B-FD42-4EFE-BD90-D272E5EEE904Q41484849-553626AF-BE64-4DBD-8897-228F8A0A09F1Q42722931-951DF487-A137-4D38-9D27-99B9D70B45E8Q43426992-01C20647-FAA9-4C7F-98FD-13C5BF5FE15FQ44148501-F594DA92-6B36-40E4-AA0C-BBC5BFC2BC02Q44437956-321DB54C-288E-4858-9F37-9B51D8E1046BQ44552314-DC417B93-1EE3-4444-B062-DF29AB081633Q44580641-7E363C47-7031-4995-A1E2-73C6E06691F5Q44627132-4D24B1B2-2C27-45F4-A132-5F960C9C92DBQ44641788-30D4598D-826A-40A4-A0D3-1A6D00672B81Q44839193-E2B2595E-4C05-4292-AB8D-8AC015AEA96CQ44899453-BB8B8539-5C7C-4CA6-8D21-AFA2D3FC432D
P50
description
researcher
@en
wetenschapper
@nl
name
Matthew D Griffin
@en
Matthew D Griffin
@nl
type
label
Matthew D Griffin
@en
Matthew D Griffin
@nl
prefLabel
Matthew D Griffin
@en
Matthew D Griffin
@nl
P106
P108
P31
P496
0000-0002-8701-8056